arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Supply shortages without end … how might we get out of this?

    NEW ON THE MARKET

    COVID-19 vaccine VIDPREVTYN BETA

    Faricimab (VABYSMO) for wet macular degeneration and diabetic macular edema (short version)

    a-t READERS QUESTIONS AND COMMENTS

    Acetylsalicylic acid for the prevention of thromboembolism?

    New data on fampridine (e.g. FAMPYRA)

    IN BRIEF

    REVLIMID (lenalidomide) 135 times more expensive than generics

    Withdrawal of accelerated approvals in the USA – atezolizumab (TECENTRIQ) for urothelial carcinoma

    SIDE EFFECTS

    Finasteride (PROPECIA, generics): additional warning in France
    free

    e a-t ON THE INTERNET

    Supply shortages of brand-name drugs

    Faricimab (VABYSMO) for wet macular degeneration and diabetic macular edema (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!